摘要
目的评价迈之灵治疗进行性色素性紫癜性皮病的临床疗效。方法 90例患者按2∶1比例随机分为治疗组和对照组,治疗组口服迈之灵片,每次300mg,每天2次;对照组口服复方丹参片,每次855 mg,每天3次,每2周观察记录一次,均治疗4周。结果治疗组在2周后的总有效率分别为70.0%,4周为95.0%,对照组则分别为50.0%和76.6%,组间疗效比较差异有统计学意义(P<0.05)。结论迈之灵是进行性色素性紫癜性皮病治疗的良好选择。
Objective To evaluate the therapeutic effect of aescuven forte on progressive pigmentary purpuric dermatosis（PPPD）. Methods Ninety cases of PPPD were divided into two groups randomly. The treat- ment group were treated by aescuven forte pill （300 mg, bid）, as the control group were treated by composite salvia pill （855 rag, tid）. The whole duration of treatment was 4 weeks. Both groups were observed and recorded every 2 weeks. Results In treatment group, the total efficacy rate was 70. 0% and 95.0% , while the total efficacy rate in the control group was 50.0% and 76.6% after 2,4 weeks , respectively. The total efficacy rates between two groups were significantly different（ P 〈 0. 05 ）. Conclusion The aescuven was a promising choice for the treatment of PPPD.
出处
《中国临床药理学杂志》
CAS
CSCD
北大核心
2012年第10期788-789,共2页
The Chinese Journal of Clinical Pharmacology
关键词
迈之灵
进行性色素性紫癜性皮病
aescuven forte
progressive pigmentary purpuric dermatosis
